Your browser doesn't support javascript.
loading
ADAR1 and its implications in cancer development and treatment.
Baker, Allison R; Slack, Frank J.
Afiliação
  • Baker AR; Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Slack FJ; Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. Electronic address: fslack@bidmc.harvard.edu.
Trends Genet ; 38(8): 821-830, 2022 08.
Article em En | MEDLINE | ID: mdl-35459560
The family of adenosine deaminases acting on RNA (ADARs) regulates global gene expression output by catalyzing adenosine-to-inosine (A-to-I) editing of double-stranded RNA (dsRNA) and through interacting with RNA and other proteins. ADARs play important roles in development and disease, including an increasing connection to cancer progression. ADAR1 has demonstrated a largely pro-oncogenic role in a growing list of cancer types, and its function in cancer has been attributed to diverse mechanisms. Here, we review existing literature on ADAR1 biology and function, its roles in human disease including cancer, and summarize known cancer-associated phenotypes and mechanisms. Lastly, we discuss implications and outstanding questions in the field, including strategies for targeting ADAR1 in cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina Desaminase / Proteínas de Ligação a RNA / Edição de RNA / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina Desaminase / Proteínas de Ligação a RNA / Edição de RNA / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos